Drawing for GENOMADIX CUBE

USPTO serial 97978739

GENOMADIX CUBE

Reviewed by CopyMark Law Group

Reg. 7980198Status 700Registered
Filing date
Status date
Registration date
Oct 14, 2025
Examiner
KONSCHAK, CARL A
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GENOMADIX CUBE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sara M. Bauer

Sara M. Bauer Womble Bond Dickinson (US) LLP470 Atlantic Avenue, Suite 600Independence WharfBoston, MA 02110

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic reagents for medical and scientific research purposes, not for medical useACTIVEJul 31, 2023
005Clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic reagents for clinical medical laboratory use; diagnostic reagents for medical diagnostic use; diagnostic reagents for medical laboratory use; medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluid; reagents for use in medical genetic testing; swabs for medical purposesACTIVEJul 31, 2023
009Biomedical diagnostic apparatus, namely, food and water safety tests for environmental monitoring; biomedical diagnostic apparatus, namely, molecular diagnostic device used for nucleic acid testing, infectious disease testing, genetic testing, and drug response testing for environmental monitoring for research purposes; biomedical devices in the nature of cartridges for loading biological samples for use in molecular diagnostic devices other than for medical use; testing sample collection equipment, namely, swabs for obtaining biological samples from subjects for research purposesACTIVEJul 31, 2023
010Biomedical diagnostic apparatus, namely, molecular diagnostic device used for nucleic acid testing, infectious disease testing, genetic testing, and drug response testing for medical monitoring purposes; biomedical diagnostic devices in the nature of cartridges for loading biological samples for use in molecular diagnostic devices for medical purposes; medical devices for obtaining body fluid samples in the nature of testing sample collection equipment comprised of swabs for obtaining biological samples from subjects for biomedical purposesACTIVEJul 31, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 14, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 26, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 26, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 20, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 22, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jun 25, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 24, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 24, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 26, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Mar 26, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 26, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 25, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 25, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 25, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025IUAAUSE AMENDMENT ACCEPTED—
Feb 13, 2025AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Aug 28, 2024DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 12, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 17, 2024AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Jun 17, 2024IUAFUSE AMENDMENT FILED—
Jun 17, 2024DRRRDIVISIONAL REQUEST RECEIVED—
Jun 17, 2024EAAUTEAS AMENDMENT OF USE RECEIVED—
Jun 17, 2024ERTDTEAS REQUEST TO DIVIDE RECEIVED—
May 31, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 31, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 30, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 20, 2024GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Mar 20, 2024GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 20, 2024CNSISUSPENSION INQUIRY WRITTEN—
Mar 20, 2024DOCKASSIGNED TO EXAMINER—
Feb 26, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 7, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 7, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 7, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 7, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 24, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 24, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Aug 24, 2023CNSLSUSPENSION LETTER WRITTEN—
Aug 16, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 16, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 16, 2023ALIEASSIGNED TO LIE—
Apr 5, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Apr 3, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 3, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 3, 2023CNSISUSPENSION INQUIRY WRITTEN—
Mar 30, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 27, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 27, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Aug 27, 2022CNSLSUSPENSION LETTER WRITTEN—
Aug 17, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 16, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 16, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2022DOCKASSIGNED TO EXAMINER—
Nov 23, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 22, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance